![](/img/cover-not-exists.png)
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
Fowler, Nathan H, Davis, R Eric, Rawal, Seema, Nastoupil, Loretta, Hagemeister, Fredrick B, McLaughlin, Peter, Kwak, Larry W, Romaguera, Jorge E, Fanale, Michelle A, Fayad, Luis E, Westin, Jason R, ShVolume:
15
Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(14)70455-3
Date:
November, 2014
File:
PDF, 262 KB
english, 2014